New York, NY USA

Our News on Newswise

Cancer Research Media Briefing

The event will include leading cancer researchers and clinicians in the field (both in and outside of Columbia University) who will discuss the future of cancer research and treatment. An update in the development of innovative cancer diagnostics...
18-Mar-2015 11:05 AM EDT

Kidney Transplant Tolerance Mechanism Identified


Researchers have pinpointed the immune system mechanism that allows a kidney transplant to be accepted without lifelong immunosuppressive drugs, a significant step toward reducing or eliminating the need for costly and potentially toxic...
16-Mar-2015 12:00 PM EDT

Neurons Controlling Appetite Made From Skin Cells


Researchers have for the first time successfully converted adult human skin cells into neurons of the type that regulate appetite, providing a patient-specific model for studying the neurophysiology of weight control and testing new therapies for...
27-Feb-2015 10:00 AM EST

Disparities in Breast Cancer Care Linked to Net Worth


Household net worth is a major and overlooked factor in adherence to hormonal therapy among breast cancer patients and partially explains racial disparities in quality of care.
23-Feb-2015 4:00 PM EST

Brain Makes Decisions with Same Method Used to Break WW2 Enigma Code

When making simple decisions, neurons in the brain apply the same statistical trick used by Alan Turing to help break Germany’s Enigma code during World War II, according to a new study in animals by researchers at Columbia University’s...
23-Feb-2015 10:00 AM EST

New ALS Gene and Signaling Pathways Identified


Using advanced DNA sequencing methods, researchers have identified a new gene that is associated with sporadic amyotrophic lateral sclerosis (ALS), or Lou Gehrig’s disease.
13-Feb-2015 5:00 PM EST

Keeping Atherosclerosis In-Check with Novel Targeted Inflammation-Resolving Nanomedicines

Nanometer-sized “drones” that deliver a special type of healing molecule to fat deposits in arteries could become a new way to prevent heart attacks caused by atherosclerosis.
13-Feb-2015 5:00 PM EST

Could There Be a Gleevec for Brain Cancer?


The drug Gleevec (imatinib mesylate) is well known not only for its effectiveness against chronic myeloid leukemia (CML) and acute lymphoblastic leukemia, but also for the story behinds its development. A similar drug might be able to tame some...
9-Feb-2015 4:45 PM EST

Our YouTube Videos